Pharmacokinetics and Pharmacodynamics of Nemonoxacin in a Neutropenic Murine Lung Infection Model Against Streptococcus Pneumoniae

Nemonoxacin, a novel nonfluorinated quinolone for the treatment of community-acquired pneumonia. We reported the pharmacokinetic/pharmacodynamic (PK/PD) targets and PK/PD breakpoints of nemonoxacin against Streptococcus pneumoniae using a neutropenic murine lung infection model. Single-dose PK analy...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xin, Chen, Yuancheng, Xu, Xiaoyong, Li, Yi, Fan, Yaxin, Liu, Xiaofen, Bian, Xingchen, Wu, Hailan, Zhao, Xu, Feng, Meiqing, Guo, Beining, Zhang, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129567/
https://www.ncbi.nlm.nih.gov/pubmed/34017256
http://dx.doi.org/10.3389/fphar.2021.658558

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129567/
https://www.ncbi.nlm.nih.gov/pubmed/34017256
http://dx.doi.org/10.3389/fphar.2021.658558

Ejemplares similares